LIST OF WITNESSES TO APPEAR BEFORE
COMMITTEE ON WAYS AND MEANS
SUBCOMMITTEE ON HEALTH
ON MEDICARE PAYMENTS FOR CURRENTLY
 COVERED PRESCRIPTION DRUGS

THURSDAY, OCTOBER 3, 2002 – BEGINNING AT 10:00 A.M.
ROOM 1100 LONGWORTH HOUSE OFFICE BUILDING

Opening Statements:

• The Honorable Nancy L. Johnson, M.C., Connecticut, and Chairwoman

• The Honorable Jim Ramstad, M.C., Minnesota

The Honorable Thomas A. Scully, Administrator, Centers for Medicare and Medicaid Services

PANEL:

George Reeb, Assistant Inspector General, Centers for Medicare and Medicaid Audits,
U.S. Department of Health and Human Services;
        accompanied by
Robert Vito, Regional Inspector General, Evaluation and Inspections, Philadelphia, Pennsylvania

Paul Bunn, Jr., M.D., Director, Cancer Center, University of Colorado, and President, American Society of Clinical Oncology, Alexandria, Virginia

Michael J. O’Grady, Ph.D., Senior Research Director, Project HOPE, Bethesda, Maryland

John D. Jones, Vice President, Legal and Regulatory Affairs, Prescription Solutions, Costa Mesa, California, on behalf of PacifiCare Health Systems, Inc.

Kim Glaun, Washington Counsel, Medicare Rights Center, New York, New York